Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen

Now Offers Patients the Choice of Administration at Home or in a Doctor's Office THOUSAND OAKS, Calif., Feb. 2, 2023 -- (Healthcare Sales & Marketing Network) -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced the U.S. Food and Drug Administration ... Biopharmaceuticals, Drug Delivery, FDA Amgen, AstraZeneca, TEZSPIRE, tezepelumab-ekko, asthma
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news